Skip to main content
MedPathMedPath Home
Clinical Trials/KCT0002038
KCT0002038
Recruiting
未知

Response-based treatment of high-risk neuroblastoma

Samsung Medical Center0 sites54 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsNeoplasms

Overview

Phase
未知
Intervention
Not specified
Conditions
Neoplasms
Sponsor
Samsung Medical Center
Enrollment
54
Status
Recruiting
Last Updated
7 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients with newly diagnosed high risk neuroblastoma
  • •2\. Patients with measurable or evaluable disease
  • •3\. Patients with informed consent

Exclusion Criteria

  • •1\. Patients with progressive disease or relapse
  • •2\. Patients who underwent high dose chemotherapy before
  • •3\. Patients with organ dysfunction as follows (creatinine elevation \> 3 x upper limit of normal, Total bilirubin \> 3 x upper limit of normal, aspartate transaminase/alanine transaminase \> 5 x upper limit of normal), ejection fraction \<40%)
  • •4\. Pregnant or nursing women

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Phase 2
Response-based Treatment of High-risk NeuroblastomaNewly Diagnosed High Risk Neuroblastoma
NCT02771743Samsung Medical Center54
Completed
Not Applicable
ovel treatment for refractory neuroblastoma by using poliovirus; phase I clinical trialrefractory neuroblastoma
JPRN-UMIN000029816Mie University3
Active, not recruiting
Phase 1
Study for the low and intermediate risk NeuroblastomaINTERMEDIATE AND LOW RISK NEUROBLASTOMAMedDRA version: 20.0Level: PTClassification code 10029260Term: NeuroblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2010-021396-81-PTInstituto de Investigación Sanitaria La Fe de Valencia520
Completed
Phase 2
Combination Chemotherapy or Observation Following Surgery in Treating Infants With NeuroblastomaNeuroblastoma
NCT00002803Children's Hospital Medical Center, Cincinnati44
Active, not recruiting
Phase 1
Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01NeuroblastomaGanglioneuroblastoma
NCT02311621Seattle Children's Hospital65